STAT+: Heart association meeting’s readout is trending ‘neutral’
The HORIZON trial taking aim at lipoprotein(a) also revealed nearly identical results, whether participants were on or off the drug.
- Continue to STAT+ to read the full story….
The ZEUS trial targeting inflammation showed no difference between the treatment and placebo arms.
CHICAGO — If one word could describe research presented at this year’s American Heart Association scientific sessions, it might be “neutral.” The meeting began with two blockbuster disappointments, hinted at in top-line results released weeks or months ago but detailed with unvarnished specificity Saturday morning.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →